Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 53, 2019 - Issue 4
Journal homepage
407
Views
12
CrossRef citations to date
0
Altmetric
Article

Incidence, survival and mortality trends of bladder cancer in Sweden 1997–2016

Per-Uno MalmströmDepartment of Urology, and Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Correspondence[email protected]
,
Truls GårdmarkUrology Section, Department of Surgery, Danderyd Hospital, Danderyd and Karolinska Institute, Stockholm, Sweden;
,
Amir SherifDepartment of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden;
,
Viveka StröckDepartment of Urology, Sahlgrenska University Hospital and Sahlgrenska Academy, Institute of Clinical Sciences, Göteborg, Sweden;
,
Abolfazl Hosseini-AliabadCenter for Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden;
,
Staffan JahnsonDepartment of Urology, Linköping University Hospital, Linköping, Sweden;
,
Firas AljaberyDepartment of Urology, Linköping University Hospital, Linköping, Sweden;
&
Fredrik LiedbergDepartment of Urology, Skåne University Hospital, Malmö, Sweden; ;Department of Translational Medicine, Lund University, Malmö, Sweden
 show all
Pages 193-199 | Received 26 Apr 2019, Accepted 11 Jun 2019, Published online: 02 Jul 2019

  • Dy GW, Gore JL, Forouzanfar M-H, et al. Global burden of urologic cancers, 1990–2013. Eur Urol. 2017;3:437–446.
  • Mariotto AB, Noone AM, Howlader N, et al. Cancer survival: an overview of measures, uses, and interpretation. J Natl Cancer Inst Monographs. 2014;2014:145–186.
  • Jahnson S, Damm O, Hellsten S, et al. A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden. Scand J Urol Nephrol. 2009;43:271–276.
  • Andersen PK, Borch-Johnsen K, Deckert T, et al. A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. Biometrics 1985;41:921–932.
  • R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017. https://www.R-project.org/
  • Perme MP, Pavlic K. Nonparametric relative survival analysis with the R package relsurv. J Stat Softw. 2018;87:1–27.
  • Chavan S, Bray F, Lortet-Tieulent J, et al. International variations in bladder cancer incidence and mortality. Eur Urol. 2014;1:59–73.
  • Nielsen ME, Smith AB, Meyer AM, et al. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006. Cancer 2014;120:86–95.
  • Jensen TK, Jensen NV, Jørgensen SM, et al. Trends in cancer of the urinary bladder and urinary tract in elderly in Denmark, 2008–2012. Acta Oncol. 2016;55:85–90.
  • Malmström PU, Thörn M, Lindblad P, et al. Increasing survival of patients with urinary bladder cancer. A nationwide study in Sweden 1960–1986. Eur J Cancer. 1993;29A:1868–1872.
  • Shah A, Rachet B, Mitry E, et al. Survival from bladder cancer in England and Wales up to 2001. Br J Cancer 2008;99:86–89.
  • Jahnson S, Hosseini Aliabad A, Holmäng S, et al. Swedish National Registry of Urinary Bladder Cancer: no difference in relative survival over time despite more aggressive treatment. Scand J Urol. 2016;50:14–20.
  • Sjöström C, Thorstenson A, Ströck V, et al. Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer. Scand J Urol. 2018;52:186–193.
  • Messing EM, Young TB, Hunt VB, et al. The significance of asymptomatic microhematuria in men 50 or more years old: findings of a home screening study using urinary dipsticks. J Urol. 1987;137:919–922.
  • Malmström PU, Skaaheim Haug E, Boström PJ, et al. Progress towards a Nordic standard for the investigation of hematuria: 2019. Scand J Urol. 2019;53:1–6.
  • Patschan O, Holmäng S, Hosseini A, et al. Second-look resection for primary stage T1 bladder cancer: a population-based study. Scand J Urol. 2017;51:1–7.
  • Gårdmark T, Bladström A, Hellsten S, et. al. Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001. Scand J Urol Nephrol. 2006;40:276–282.
  • Sherif A, Holmberg L, Rintala E, et al. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies. Eur Urol. 2004;45:297–303.
  • Andreassen BK, Aagnes B, Gislefoss R, et al. Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981–2014. BMC Cancer. 2016;16:799
  • Häggström C, Liedberg F, Hagberg O, et al. Cohort profile: the Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe). BMJ Open. 2017;7:e016606.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.